Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Influenza
Intervention:
Sponsor: QIAGEN Gaithersburg, Inc
Recruiting - verified March 2010
Condition: Influenza Vaccines
Intervention: Biological: egg-derived A/H1N1 pandemic influenza vaccine
Sponsor: Opera Srl
Recruiting - verified March 2010
Condition: Seasonal Human Influenza
Interventions: Biological: GHB11L1; Biological: Placebo
Sponsor: AVIR Green Hills Biotechnology AG
Recruiting - verified March 2010
Condition: Influenza A Virus/H5N1 Subtype
Intervention:
Sponsors: South East Asia Infectious Disease Clinical Research Network; University of Oxford; Wellcome Trust
Not yet recruiting - verified February 2010
Condition: Amyotrophic Lateral Sclerosis
Intervention: Biological: autologous bone marrow-derived stem cells
Sponsor: TCA Cellular Therapy
Recruiting - verified March 2010
Condition: Acute Otitis Media
Intervention: Procedure: Sample Collection
Sponsor: GlaxoSmithKline
Not yet recruiting - verified February 2010
Conditions: Respiratory Tract Infections; Influenza
Interventions: Dietary Supplement: Cholecalciferol (Vitamin D/Vigantol oil); Dietary Supplement: Miglyol oil
Sponsors: Barts & The London NHS Trust; National Health Service, United Kingdom
Not yet recruiting - verified February 2010
Condition: Swine-Origin Influenza A H1N1 Virus
Intervention: Biological: Emulsion, Cell Culture-based, influenza HA vaccine H1N1
Sponsors: Novartis; Novartis Vaccines
Not yet recruiting - verified February 2010
Condition: Immunocompromised
Intervention: Biological: Focetria (2x H1N1 vaccine with MF59 adjuvants)
Sponsor: Competence Network Viral Hepatitis
Recruiting - verified February 2010
Conditions: Malnutrition; Aged
Interventions: Dietary Supplement: Standard ONS (Fortisip, Fortisp Extra or Fortisip Multifibre); Dietary Supplement: High Energy, low volume ONS (Cooper, Cooper Fibre, Cooper Protein)
Sponsor: Nutricia UK Ltd
Recruiting - verified March 2010
Condition: Influenza
Interventions: Drug: Favipiravir; Drug: Favipiravir; Drug: Placebo comparator
Sponsor: Toyama Chemical Co., Ltd.
Recruiting - verified March 2010
Condition: Influenza
Intervention: Dietary Supplement: Prebiotic and probiotic mix
Sponsor: University of Reading
Not yet recruiting - verified February 2010
Condition: Physical and Psychological Evaluation of Hormonal Therapy in Transsexual Persons
Interventions: Other: questionnaires; Biological: blood sampling; Other: clinical evaluation; Other: Dermatology evaluation; Other: Bone evaluation
Sponsor: University Hospital, Ghent
Recruiting - verified February 2010
Condition: Influenza
Intervention: Biological: Seasonal influenza vaccine (split virion, inactivated, prepared in Vero Cell cultures)
Sponsor: Baxter Healthcare Corporation
Recruiting - verified March 2010
Condition: Influenza
Intervention: Drug: Peramivir
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified January 2010
Condition: Healthy Elderly People
Interventions: Dietary Supplement: VSL#3® probiotic blend; Dietary Supplement: AISA-5203-L fruit extracted terpene; Dietary Supplement: Argan oil; Behavioral: Optimal Diet
Sponsor: University Hospital, Bordeaux
Not yet recruiting - verified February 2010
Condition: Influenza
Interventions: Biological: GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340274A; Biological: GSK Biologicals' FluLaval®; Biological: Placebo (saline); Biological: GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340273A
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Influenza
Interventions: Drug: Nitazoxanide; Drug: Placebo
Sponsor: Romark Laboratories L.C.
Recruiting - verified February 2010
Condition: Influenza
Intervention: Drug: oseltamivir [Tamiflu]
Sponsor: Hoffmann-La Roche
Not yet recruiting - verified February 2010
Condition: Pandemic H1N1 Influenza
Interventions: Biological: GSK Biologicals' investigational vaccine GSK2340273A (alternative formulations); Biological: GSK Biologicals' investigational vaccine GSK2340274A (alternative formulations)
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Influenza
Interventions: Drug: Oseltamivir; Drug: Oseltamivir
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Non-small Cell Lung Cancer
Interventions: Dietary Supplement: IMN1207; Dietary Supplement: Casein
Sponsor: Immunotec Inc.
Not yet recruiting - verified February 2010
Condition: Influenza
Intervention: Other: Non-intervention observational study
Sponsors: Novartis; Novartis Vaccines
Recruiting - verified February 2010
Conditions: Novel Influenza A (H1N1); A New Flu Virus of Swine Origin
Intervention: Other: Non-intervention observational study
Sponsors: Novartis; Novartis Vaccines
Recruiting - verified March 2010
Conditions: H1N1 Subtype; Influenza A
Interventions: Biological: GSK Biologicals' Influenza investigational vaccine GSK2340273A; Biological: Placebo (saline); Biological: GSK Biologicals' Influenza investigational vaccine GSK2340274A
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Influenza
Intervention: Drug: oseltamivir [Tamiflu]
Sponsor: Hoffmann-La Roche
Not yet recruiting - verified February 2010
Condition: Influenza
Interventions: Drug: Oseltamivir; Drug: Oseltamivir; Drug: Oseltamivir; Drug: Oseltamivir
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Conditions: Influenza A Virus, H1N1 Subtype; Influenza B Virus; Influenza, Human; Influenza, Seasonal
Intervention: Drug: zanamivir aqueous solution
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Condition: Recurrent Grade IV Malignant Glioma
Intervention: Drug: Panitumumab in Combination with Irinotecan
Sponsors: Duke University; Amgen
Recruiting - verified February 2010
Condition: Influenza Infection
Interventions: Biological: Prevenar; Biological: GSK2340272A GSK Biologicals' investigational influenza pandemic vaccine; Biological: InfanrixTM-IPV/Hib
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Condition: Autoimmune Diseases
Intervention: Biological: Evaluation of vaccines against flu
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - verified February 2010
Conditions: Haemophilus Influenzae Type B Related Disease; Pneumonia; Meningitis; Cellulitis; Osteomyelitis; Epiglottis
Interventions: Biological: InfanrixTM; Biological: GSK Biologicals' Haemophilus inluenzae type b vaccine (GSK 208108); Biological: ActHIBTM; Biological: PentacelTM; Biological: PediarixTM; Biological: PrevnarTM; Biological: RotarixTM; Biological: EngerixTM-B
Sponsor: GlaxoSmithKline
Not yet recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Biological: Placebo; Biological: Certolizumab pegol
Sponsor: UCB, Inc.
Recruiting - verified February 2010
Condition: Influenza
Intervention: Biological: Inactivated Influenza H1N1 vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2010
Condition: Influenza
Intervention: Biological: Inactivated H1N1 Vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2009
Condition: Diseases Caused by Streptococcus Pneumoniae and Non-typable Haemophilus Influenzae
Interventions: Biological: Pneumococcal vaccine GSK2189242A (formulation 1); Biological: Pneumococcal vaccine GSK2189242A (formulation 2); Biological: Pneumococcal vaccine GSK2189242A combined with pneumococcal vaccine GSK1024850A (formulation 4); Biological: Pneumococcal vaccine GSK1024850A; Biological: Pneumococcal vaccine GSK2189242A combined with pneumococcal vaccine GSK1024850A (formulation 3)
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Condition: Influenza Infection
Interventions: Biological: GSK2340273A; Biological: GSK2340274A
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Leukemia; Non-Hodgkins Lymphoma; Hodgkins Lymphoma; MDS; Multiple Myeloma
Interventions: Drug: EPOCH-F/R; Drug: FLAG; Drug: Transplant Preparative Regimen (Flu/Cy/Mes); Drug: GVHD Prophylaxis (tacrolimus and sirolimus); Procedure: Double Cord Blood Transplantation
Sponsor: National Cancer Institute (NCI)
Recruiting - verified November 2009
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Nonmalignant Neoplasm
Interventions: Biological: trivalent influenza vaccine; Other: immunoenzyme technique; Other: laboratory biomarker analysis
Sponsors: Beckman Research Institute; National Cancer Institute (NCI)
Recruiting - verified August 2009
Conditions: Seasonal Influenza; Cough; Sore Throat; Nasal Congestion; Myalgia; Headache; Fatigue
Interventions: Drug: Peramivir; Drug: Peramivir
Sponsors: BioCryst Pharmaceuticals; Department of Health and Human Services
Recruiting - verified March 2010
Conditions: Cough; Sore Throat; Nasal Congestion; Headache; Fever; Seasonal Influenza
Interventions: Drug: Peramivir 600mg; Drug: Peramivir 10 mg
Sponsors: BioCryst Pharmaceuticals; Department of Health and Human Services
Recruiting - verified March 2010
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Nonmalignant Neoplasm; Viral Infection
Interventions: Other: cytology specimen collection procedure; Other: fluorescent antibody technique; Procedure: assessment of therapy complications
Sponsors: Beckman Research Institute; National Cancer Institute (NCI)
Recruiting - verified August 2009
Condition: Influenza
Interventions: Drug: oseltamivir [Tamiflu]; Drug: oseltamivir [Tamiflu]
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Bone Scan
Intervention: Other: 18F-Sodium Fluoride (Na18F)
Sponsor: Alberta Health Services
Recruiting - verified November 2009
Condition: Influenza
Interventions: Biological: A/Anhui/05; Biological: MF-59; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified December 2009
Condition: Haemophilus Influenzae (NTHI)
Intervention: Biological: NTHi Strain 2019
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified December 2009
Condition: Aplastic Anemia
Intervention: Drug: Cyclophosphamide, Fludarabine, Thymoglobulin
Sponsor: The Korean Society of Pediatric Hematology Oncology
Recruiting - verified February 2010
Condition: Osteoarthritis
Interventions: Drug: Naproxen; Drug: Placebo
Sponsors: Pfizer; King's College London; St Thomas' Hospital, London
Not yet recruiting - verified February 2010
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: fludarabine phosphate; Drug: melphalan; Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation; Radiation: intensity-modulated radiation therapy; Radiation: tomotherapy; Radiation: total marrow irradiation; Radiation: total nodal irradiation
Sponsors: Beckman Research Institute; National Cancer Institute (NCI)
Recruiting - verified June 2009
Condition: Hematological Malignancies
Interventions: Procedure: full intensity, double umbilical cord, stem cell transplant; Drug: Flu/Bu4 conditioning regimen; Radiation: Total Lymphoid Irradiation (TLI); Drug: Graft versus Host Disease prevention (GVHD prophylaxis)
Sponsor: University of Michigan Cancer Center
Recruiting - verified February 2010
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
